- Home
- CDTX vs CMRE Comparison
CDTX vs CMRE Comparison
Compare CDTX & CMRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDTX
- CMRE
- Stock Information
- Founded
- CDTX 2012
- CMRE 1974
- Country
- CDTX United States
- CMRE Monaco
- Employees
- CDTX N/A
- CMRE N/A
- Industry
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- CMRE Marine Transportation
- Sector
- CDTX Health Care
- CMRE Consumer Discretionary
- Exchange
- CDTX Nasdaq
- CMRE Nasdaq
- Market Cap
- CDTX 980.1M
- CMRE 1.0B
- IPO Year
- CDTX 2015
- CMRE 2010
- Fundamental
- Price
- CDTX $63.31
- CMRE $10.10
- Analyst Decision
- CDTX Strong Buy
- CMRE Hold
- Analyst Count
- CDTX 11
- CMRE 1
- Target Price
- CDTX $52.11
- CMRE $13.00
- AVG Volume (30 Days)
- CDTX 659.9K
- CMRE 453.4K
- Earning Date
- CDTX 08-07-2025
- CMRE 07-31-2025
- Dividend Yield
- CDTX N/A
- CMRE 4.56%
- EPS Growth
- CDTX N/A
- CMRE N/A
- EPS
- CDTX N/A
- CMRE 2.28
- Revenue
- CDTX $302,000.00
- CMRE $2,085,912,000.00
- Revenue This Year
- CDTX N/A
- CMRE N/A
- Revenue Next Year
- CDTX N/A
- CMRE N/A
- P/E Ratio
- CDTX N/A
- CMRE $3.76
- Revenue Growth
- CDTX N/A
- CMRE 10.60
- 52 Week Low
- CDTX $10.14
- CMRE $6.63
- 52 Week High
- CDTX $66.95
- CMRE $15.96
- Technical
- Relative Strength Index (RSI)
- CDTX 70.66
- CMRE 62.96
- Support Level
- CDTX $60.71
- CMRE $9.38
- Resistance Level
- CDTX $66.95
- CMRE $9.79
- Average True Range (ATR)
- CDTX 4.25
- CMRE 0.29
- MACD
- CDTX -0.39
- CMRE 0.03
- Stochastic Oscillator
- CDTX 79.25
- CMRE 86.41
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
About CMRE Costamare Inc. $0.0001 par value
Costamare Inc is an international owner and operator of containerships and dry bulk vessels. The company charter its containerships to the liner companies, providing transportation of containerized cargoes. It charter its dry bulk vessels to a wide variety of customers, providing transportation for dry bulk cargoes. The company's fleet of vessels includes Cosco Guangzhou, Cosco Ningbo, Cosco Yantian, Vantage, Valor, Valiant, Maersk Kobe, and among others. Costamare provides services to ocean carriers that demand a high standard of safety and reliability. It generates a majority of its revenue from the United States of America.